A blockbuster international deal announced Wednesday, in which New Jersey-based health products giant Johnson & Johnson has agreed to buy medical device maker Synthes for $21.3 billion, could have a ...

The sentencing of three of the four ex-directors of medical device manufacturer Synthes to terms ranging from five to nine months over the unauthorized use of bone cement in spinal surgery clinical ...

Leslie Storms started a new role on Monday as president of Ethos Veterinary Health.

Four top executives with West Chester, PA-based Synthes Inc. were indicted by the US Attorney for the Eastern District of Pennsylvania on charges that the company improperly engaged in off-label ...

PHILADELPHIA -- A Swiss company with major operations in West Chester, Pa., illegally tested its bone cement on about 200 people, three of whom died, according to a 52-count indictment issued Tuesday, ...

Johnson & Johnson plans to spin off its orthopedics business into a standalone company. The move comes as part of a bid to focus J&J’s medical technology division on faster-growing areas. In an Oct.

Last week, Fortune posted online an exposé titled "Bad to the bone: A medical horror story." The story centers around Norian XR, a calcium compound bone void filler linked to the deaths of at least ...

Please provide your email address to receive an email when new articles are posted on . Synthes, Inc. announced that it has acquired The Anspach Effort, Inc., a global company in the high-speed ...

ZURICH (Reuters) - Swiss medical device maker Synthes posted a 24 percent rise in net profit to $348.8 million in the first-half of the year as high demand across all regions and product lines boosted ...

Johnson & Johnson MedTech’s orthopedics division, DePuy Synthes, has claimed an FDA clearance for its Velys surgical robot that expands its use into partial knee replacements. While total knee ...

TRENTON, N.J. (AP) -- Healthcare giant Johnson & Johnson said Tuesday that it will complete its $19.7 billion purchase of Synthes on Thursday — a deal J&J hopes will give it a dominant position in the ...

Johnson & Johnson MedTech has secured an FDA 510(k) clearance for its first robotically guided platform for spine surgery and has slated its commercial launch for the first half of next year. The ...